APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
The clinical significance of the SLCO1B1 gene polymorphism (encoding an organic anion transport polipeptide) in the development of statin induced myopathy is considered. Possible tactics of statin dose determination on the basis of pharmacogenetic testing is discussed. Indications for the use of thi...
Saved in:
Main Authors: | D. A. Sychev (Author), G. N. Shuev (Author), A. B. Prokofiev (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015) -
Statin-Induced Myopathy
by: D. A. Sychev, et al.
Published: (2023) -
Clinical case of statin-induced myopathy in female patient with compensated hypothyroidism and unfavorable polymorphic variant of SLCO1B1*5 (c.521T>C)
by: Liya A. Lugovaya, et al.
Published: (2021) -
STATINS, MYOPATHY AND PHYSICAL ACTIVITY
by: Elena SÎRBU, et al.
Published: (2018) -
STATINS AND MYOPATHY: MOLECULAR MECHANISMS
by: O. M. Drapkina, et al.
Published: (2015)